CNN

Bio-Techne's Ella On The Front Lines In Fight Against COVID-19

MINNEAPOLIS, March 25, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today shared news from clinical partners on the use of the ProteinSimple™-branded Ella™ Automated Immunoassay platform ...
CNN

Bio-Techne Continues to Expand Its Portfolio to Support SARS-CoV-2 and COVID-19 Research and Therapeutic Development

MINNEAPOLIS, June 9, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) is at the forefront of coronavirus disease 2019 (COVID-19) and SARS-CoV-2 research. This is evidenced by the large number ...
Morningstar

Bio-Techne Begins Fiscal 2021 on Track, Benefiting From Capacity Growth and Coronavirus Research

Narrow-moat Bio-Techne reported strong fiscal first-quarter earnings, with year-over-year organic revenue up 10% and EPS of $0.83, up from $0.37 last year. While revenue is tracking slightly ahead of ...